Arsenic Trioxide [UN1561] [Poison] en es it fr

Arsenic Trioxide [UN1561] [Poison] Brand names, Arsenic Trioxide [UN1561] [Poison] Analogs

Arsenic Trioxide [UN1561] [Poison] Brand Names Mixture

  • No information avaliable

Arsenic Trioxide [UN1561] [Poison] Chemical_Formula

As2O3

Arsenic Trioxide [UN1561] [Poison] RX_link

http://www.rxlist.com/cgi/generic2/arsenic.htm

Arsenic Trioxide [UN1561] [Poison] fda sheet

Arsenic_Trioxide_[UN1561]_[Poison] FDA

Arsenic Trioxide [UN1561] [Poison] msds (material safety sheet)

Arsenic Trioxide [UN1561] [Poison] Synthesis Reference

No information avaliable

Arsenic Trioxide [UN1561] [Poison] Molecular Weight

197.841 g/mol

Arsenic Trioxide [UN1561] [Poison] Melting Point

No information avaliable

Arsenic Trioxide [UN1561] [Poison] H2O Solubility

No information avaliable

Arsenic Trioxide [UN1561] [Poison] State

Solid

Arsenic Trioxide [UN1561] [Poison] LogP

No information avaliable

Arsenic Trioxide [UN1561] [Poison] Dosage Forms

Tablet

Arsenic Trioxide [UN1561] [Poison] Indication

For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL), and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression

Arsenic Trioxide [UN1561] [Poison] Pharmacology

Arsenic Trioxide is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy.

Arsenic Trioxide [UN1561] [Poison] Absorption

No information avaliable

Arsenic Trioxide [UN1561] [Poison] side effects and Toxicity

Symptoms of overdose include convulsions, muscle weakness and confusion.

Arsenic Trioxide [UN1561] [Poison] Patient Information

No information avaliable

Arsenic Trioxide [UN1561] [Poison] Organisms Affected

Humans and other mammals